Literature DB >> 23832286

Predictive factors that influence the course of medullary thyroid carcinoma.

Kalliopi Pazaitou-Panayiotou1, Alexandra Chrisoulidou, Stylianos Mandanas, Konstantinos Tziomalos, Eleni Doumala, Frideriki Patakiouta.   

Abstract

BACKGROUND: Medullary thyroid cancer (MTC) is an infrequent form of thyroid cancer. We aimed to examine how gender and histological characteristics influence the rate of recurrence/persistent disease, distant metastases and survival and also to define specific characteristics of MTC microcarcinomas.
METHODS: The medical records of 85 patients with MTC were reviewed. The following characteristics were recorded: year of diagnosis, age at diagnosis, sex, tumor size, number of tumor foci, lymph node metastases, thyroid capsule and vascular invasion, infiltration of thyroid parenchyma and extrathyroid extension, and distant metastases.
RESULTS: During follow-up (mean 78.8 months), persistent disease occurred in 40 patients, local recurrences in 5 and distant metastases in 32 patients. Local and distant disease appeared more frequently in patients with larger tumors (p < 0.005) and lymph node metastases (p < 0.01). In addition, patients with invasive tumors had local and distant disease more frequently. The percentage of males who had persistent disease and/or local recurrence was significantly higher than the percentage of males who did not (p < 0.05). Similar results were observed for distant disease (p < 0.01). Independent predictors of recurrence and persistent disease was the presence of lymph node metastases at diagnosis (risk ratio 11.66) and of distant metastases were the presence of lymph node metastases at diagnosis (risk ratio 17.42) and the presence of vascular invasion (risk ratio 2.41). Fifteen patients died due to MTC during follow-up (17.6 %). Patients who died were more frequently males, and had thyroid capsule invasion, extrathyroidal extension, vascular invasion and metastatic disease.
CONCLUSIONS: Male sex, tumor size and invasive characteristics of the tumor are negative predictive factors for evolution of MTC.

Entities:  

Mesh:

Year:  2013        PMID: 23832286     DOI: 10.1007/s10147-013-0588-8

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  26 in total

1.  Survival implications of cervical lymphadenectomy in patients with medullary thyroid cancer.

Authors:  Emad Kandil; Marta M Gilson; Haytham H Alabbas; Anthony P Tufaro; Alan Dackiw; Ralph P Tufano
Journal:  Ann Surg Oncol       Date:  2010-10-29       Impact factor: 5.344

Review 2.  Medullary thyroid carcinoma.

Authors:  F Pacini; M G Castagna; C Cipri; M Schlumberger
Journal:  Clin Oncol (R Coll Radiol)       Date:  2010-08       Impact factor: 4.126

3.  Prognostic variables and calcitonin in medullary thyroid cancer.

Authors:  Jonathan R Clark; Tauba R Fridman; Michael J Odell; James Brierley; Paul G Walfish; Jeremy L Freeman
Journal:  Laryngoscope       Date:  2005-08       Impact factor: 3.325

4.  Early diagnosis and curative therapy of medullary thyroid carcinoma by routine measurement of serum calcitonin in patients with thyroid disorders.

Authors:  H Vierhapper; B Niederle; C Bieglmayer; K Kaserer; S Baumgartner-Parzer
Journal:  Thyroid       Date:  2005-11       Impact factor: 6.568

5.  Multivariate analysis of prognostic factors in sporadic medullary carcinoma of the thyroid. A retrospective study of 109 consecutive patients.

Authors:  L Scopsi; G Sampietro; P Boracchi; R Del Bo; M Gullo; M Placucci; S Pilotti
Journal:  Cancer       Date:  1996-11-15       Impact factor: 6.860

6.  Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients.

Authors:  M R Pelizzo; I M Boschin; P Bernante; A Toniato; A Piotto; C Pagetta; O Nibale; L Rampin; P C Muzzio; D Rubello
Journal:  Eur J Surg Oncol       Date:  2006-11-27       Impact factor: 4.424

7.  Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients.

Authors:  M F Saad; N G Ordonez; R K Rashid; J J Guido; C S Hill; R C Hickey; N A Samaan
Journal:  Medicine (Baltimore)       Date:  1984-11       Impact factor: 1.889

8.  Long-term clinical and biochemical follow-up in medullary thyroid carcinoma: a single institution's experience over 20 years.

Authors:  Kenko Cupisti; Achim Wolf; Andreas Raffel; Matthias Schott; Daniel Miersch; Qin Yang; Claus F Eisenberger; Hans D Röher; Wolfram T Knoefel
Journal:  Ann Surg       Date:  2007-11       Impact factor: 12.969

9.  Medullary thyroid cancer: a retrospective analysis of a cohort treated at a single tertiary care center between 1970 and 2005.

Authors:  Simona Grozinsky-Glasberg; Carlos A Benbassat; Gloria Tsvetov; Rafael Feinmesser; Hava Peretz; Ilan Shimon; Mordechai Lapidot
Journal:  Thyroid       Date:  2007-06       Impact factor: 6.568

Review 10.  Recent advances in the molecular pathogenesis and targeted therapies of medullary thyroid carcinoma.

Authors:  Madson Q Almeida; Ana O Hoff
Journal:  Curr Opin Oncol       Date:  2012-05       Impact factor: 3.645

View more
  5 in total

Review 1.  Consensus on management of advanced medullary thyroid carcinoma on behalf of the Working Group of Thyroid Cancer of the Spanish Society of Endocrinology (SEEN) and the Spanish Task Force Group for Orphan and Infrequent Tumors (GETHI).

Authors:  E Grande; J Santamaría Sandi; J Capdevila; E Navarro González; C Zafón Llopis; T Ramón Y Cajal Asensio; J M Gómez Sáez; P Jiménez-Fonseca; G Riesco-Eizaguirre; J C Galofré
Journal:  Clin Transl Oncol       Date:  2015-12-21       Impact factor: 3.405

2.  Outcomes of surgery and postoperative radiation therapy in managing medullary thyroid carcinoma.

Authors:  Andries H Groen; Thomas H Beckham; Thera P Links; Debra A Goldman; Eric J Sherman; Michael M Tuttle; Hendrik P Bijl; Richard J Wong; John Th M Plukker; Nancy Y Lee
Journal:  J Surg Oncol       Date:  2019-11-16       Impact factor: 3.454

3.  Medullary thyroid cancer: epidemiological pattern and factors contributing to recurrence and metastasis.

Authors:  O Hamdy; S Awny; I H Metwally
Journal:  Ann R Coll Surg Engl       Date:  2020-04-01       Impact factor: 1.891

4.  Postoperative Neck Ultrasonography Surveillance After Thyroidectomy in Patients With Medullary Thyroid Carcinoma: A Multicenter Study.

Authors:  Hye Shin Ahn; Dong Wook Kim; Yoo Jin Lee; Chang Yoon Lee; Ji-Hoon Kim; Yoon Jung Choi; Song Lee; Inseon Ryoo; Jung Yin Huh; Jin Yong Sung; Jin Young Kwak; Hye Jin Baek
Journal:  Front Endocrinol (Lausanne)       Date:  2018-03-15       Impact factor: 5.555

5.  Spindle cell variant of medullary thyroid carcinoma: a clinicopathologic study of four cases.

Authors:  Yan Xia Wang; Shou Jing Yang
Journal:  Diagn Pathol       Date:  2021-11-27       Impact factor: 2.644

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.